SOURCE: LIFEFORCE Medical Institute Dr. Mark Rosenbloom, Founder of LIFEFORCE Medical Institute in Chicago, and Renowned Expert in Age Management and Hormone Replacement Therapy, Was Prominently Featured in the Current Jan-Feb Issue of Playboy Magazine for His Expertise on the Subject of Testosterone Replacement Therapy for Men NORTHBROOK, IL--(Marketwired - January 26, 2015) - Alarming scientific evidence recently presented in a well-researched report in Playboy Magazine shows American men 35 to 70 years old are plagued with testosterone levels significantly lower than their fathers before them. Dr. Mark Rosenbloom, founder of LIFEFORCE Medical Institute in Chicago, was referenced and quoted by Playboy throughout their January/February, 2015 cover story entitled "How Low T Became the Disease du Jour." A study cited by Playboy from the Journal of Clinical Endocrinology & Metabolism shows a 22 percent drop in male testosterone levels since the late 1980s. Some scientists blame record low levels of testosterone on a combination of environmental factors such as phytoestrogens in plants like soy, flame retardants in computers and furniture, and BPA in plastic containers. Researchers say Low T could be responsible for a host of problems such as hypertension, high cholesterol, obesity, low sex drive, low energy levels and … Continue reading →

PLAINSBORO, N.J., Jan. 26, 2015 /PRNewswire/ --Novo Nordisk announced today the U.S. Food and Drug Administration (FDA) approval of Norditropin (somatropin [rDNA origin] injection) FlexPro 30 mg/3.0 mL, a prefilled injection pen for patients with growthhormone-related disorders. The FlexPro 30 mg/3.0 mL device complements the existing portfolio of Norditropin FlexPro products available in 5 mg/1.5 mL, 10 mg/1.5 mL and 15 mg/1.5 mL pens. "Novo Nordisk is committed to advancing growth hormone delivery devices with patients in mind," said Eddie Williams, senior vice president, Biopharmaceuticals, Novo Nordisk. "This approval marks another option for patients who may need higher doses of treatment." The availability of four different strengths of Norditropin FlexPro enhances physicians' ability to better address the unique needs of appropriate patients on treatment. Each Norditropin FlexPro pen is prefilled with Norditropin, and is color coded to differentiate the various strengths. Novo Nordisk plans to make Norditropin FlexPro 30 mg/3.0 mL available by April 2015. Visit http://www.norditropin.comfor more information on Norditropin. Indications and UsageWhat is Norditropin (somatropin [rDNA origin] injection)? Norditropin is a prescription medicine that contains human growth hormone and is used to treat: Important Safety InformationWho should not use Norditropin?Do not use Norditropin if: What should I tell … Continue reading →

Sarah Broom, 42, was suddenly struggling to control her asthma The nurse from Sutton Coldfield, West Midlands, rarely had symptoms Her condition was controlled with her preventer and reliever inhalers But tests showed levels of airflow dropped shortly before every period By Cara Lee for the Daily Mail Published: 19:41 EST, 26 January 2015 | Updated: 20:34 EST, 26 January 2015 Sarah Broom, 42, had no idea why she was suddenly struggling to control her asthma symptoms Sarah Broom had no idea why she was suddenly struggling to control her asthma symptoms. The nurse had been diagnosed with the condition in 2006, after developing a tickly cough and wheeze. But once diagnosed, she rarely had asthma symptoms as her condition was controlled with her preventer and reliever inhalers. Then, in March 2011, she had an asthma attack and was admitted to hospital after going to A&E. 'I was wheezing, coughing a lot at night and couldn't breathe properly - but, unusually, my reliever inhaler wasn't helping,' says Sarah, 42, from Sutton Coldfield, West Midlands. Doctors gave her stronger medications, including a nebuliser, which creates a mist of higher-dose medicine breathed in through a mask, and steroid tablets to reduce the … Continue reading →